Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: A case report
(Impact Factor: 4).
10/2008; 3(4):253-258. DOI: 10.1007/s11523-008-0094-5
The vast majority of colorectal cancer patients who present with liver metastases are not initially candidates for hepatic
resection. Although the combination of systemic chemotherapy and liver surgery can convert a significant proportion of patients
from a palliative situation to a potentially curative situation, the majority of initially unresectable liver metastases do
not respond sufficiently to initial chemotherapy to become resectable. More recently the addition of biologic agents (bevacizumab
or cetuximab) to cytotoxic chemotherapy has increased the rate of tumor response, suggesting that the addition of these agents
could improve resectability rate. Here we report the clinical case of a complete pathological response (pCR) in a 67-year-old
male affected by metastatic colorectal cancer, with initially unresectable liver metastases, after treatment with chemotherapy
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.